Ping An Biomedical Receives Nasdaq Minimum Bid Price Deficiency Notice
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 28 2025
0mins
Source: Newsfilter
- Compliance Issue: Ping An Biomedical received a notice from Nasdaq on November 24, 2025, indicating that it failed to meet the minimum bid price requirement of $1 per share based on its closing prices from October 10 to November 20, 2025, posing a risk to its listing status.
- Compliance Period: The company has been granted a compliance period of 180 calendar days until May 25, 2026, and may be eligible for an additional 180 days if it meets other listing standards, highlighting the urgency of its situation.
- Reverse Stock Split Option: Should the company fail to regain compliance within the initial period, it may need to consider a reverse stock split to meet Nasdaq's requirements, introducing further uncertainty into its stock strategy.
- Efforts to Comply: The company is currently evaluating options to regain compliance and is committed to making all reasonable efforts to meet Nasdaq's continued listing requirements, although there is no guarantee of success.
Analyst Views on PASW
About PASW
Ping An Biomedical Co Ltd, formerly known as Majestic Ideal Holdings Ltd, is an investment holding company mainly engaged in the provision of apparel supply chain management services (SCM services). The Company operates its business through two segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. The Company provides end-to-end supply chain solutions. The Company provides services covering functions within the supply chain of these products, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
